Clinical Report: Initiating Continuous Glucose Monitoring in Insulin-Treated Adults

Overview

This cohort study evaluates the clinical impact of continuous glucose monitoring (CGM) initiated by primary care clinicians in a diverse patient population. The findings indicate changes in hemoglobin A1c (HbA1c) levels and hospitalizations and emergency department visits.

Background

Continuous glucose monitoring (CGM) is recommended by the American Diabetes Association for insulin-treated diabetes patients. Despite its benefits, CGM adoption in primary care remains limited, particularly among underrepresented populations. Understanding the outcomes of CGM initiated in primary care is essential for its integration into routine diabetes management.

Data Highlights

No numerical data provided in the source material.

Key Findings

• CGM use can reduce HbA1c levels in both type 1 and type 2 diabetes patients.
• Primary care settings are ideal for CGM integration due to their role in diabetes management.
• Limited studies have evaluated the clinical impact of CGM when initiated by primary care clinicians.
• The study focuses on a population that is predominantly Hispanic and Black, groups with historically low CGM uptake.

Clinical Implications

The study presents data on CGM initiated by primary care clinicians for diabetes management.

Conclusion

The findings from this study provide data on the effectiveness of CGM initiated in primary care.

Related Resources & Content

1. American Diabetes Association, Diabetes Care, 2026 -- Diabetes Technology: Standards of Care in Diabetes—2026
2. Frontiers in Endocrinology, 2026 -- Impact of real-time continuous glucose monitoring on glycaemic control in adults with type 2 diabetes: systematic review and meta-analysis
3. Diabetology & Metabolic Syndrome, 2025 -- Efficacy of intermittently scanned continuous glucose monitoring in patients with types 1 or 2 diabetes receiving insulin therapy: a systematic review and meta-analysis
4. conexiant — Expanding CGM Access for Medicare Patients
5. aace endocrine ai — Randomized trial finds continuous glucose monitoring improves TIR
6. aace endocrine ai — Remote CGM monitoring may improve glycemic outcomes
7. conexiant — CGM in Early Gestational Diabetes Improved Outcomes
8. Expanding CGM Access for Medicare Patients
9. Randomized trial finds continuous glucose monitoring improves TIR
10. Remote CGM monitoring may improve glycemic outcomes
11. 7. Diabetes Technology: Standards of Care in Diabetes—2026 | Diabetes Care | American Diabetes Association
12. Impact of real-time continuous glucose monitoring on glycaemic control in adults with type 2 diabetes: systematic review and meta-analysis
13. Efficacy of intermittently scanned continuous glucose monitoring in patients with types 1 or 2 diabetes receiving insulin therapy: a systematic review and meta-analysis | Diabetology & Metabolic Syndrome | Springer Nature Link
14. Continuous Glucose Monitoring in Type 2 Diabetes Patients with Basal-Only Insulin Regimens | NEJM Clinician